| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.1M | +33.4% |
| Cost of Revenue | $7.3M | +12.8% |
| Gross Profit | $12.8M | +48.9% |
| R&D Expense | $9.7M | -5.6% |
| SG&A Expense | $5.6M | +0.9% |
| Operating Income | -$8.8M | +32.2% |
| Income Tax | $0 | — |
| Net Income | -$10.8M | +32.7% |
| EPS (Basic) | -$1.12 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.2M | +7.4% |
| Inventory | $1.8M | +19.9% |
| Current Assets | $12.5M | +157.5% |
| Total Assets | $24.9M | +31.1% |
| Current Liabilities | $6.2M | -64.2% |
| Total Liabilities | $17.1M | -33.7% |
| Stockholders' Equity | -$12.2M | -79.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +50.5% |
| Capital Expenditures | $381K | +274.5% |
| Investing Cash Flow | -$752K | -639.5% |
| Financing Cash Flow | $14.6M | +46.0% |
| Free Cash Flow | -$7.0M | +48.1% |
| +50.2% |